Spevatamig Antibody
Spevatamig is a bispecific antibody with a human IgG1/kappa format that simultaneously targets CD47 and CLDN18. It is utilized in research to investigate potential therapeutic strategies in oncology, particularly in preclinical in vitro and in vivo models for solid tumors.
Product Specifications
Target
Immunology/Inflammation related
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GQB45769-01 50 mg
5-[ (4-Nitro-1H-pyrazol-1-yl) methyl]thiophene-2-carboxylic acid
Sign In for Pricing
View Details GQB45769-02 0.5 g
5-[ (4-Nitro-1H-pyrazol-1-yl) methyl]thiophene-2-carboxylic acid
Sign In for Pricing
View Details